Great Lakes Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-14,934
Closed -$2.1M – 764
2023
Q2
$2.1M Sell
14,934
-2,855
-16% -$394K 0.02% 438
2023
Q1
$2.52M Sell
17,789
-49,415
-74% -$7.07M 0.02% 475
2022
Q4
$1.05M Buy
67,204
+18,929
+39% +$2.72M 0.06% 413
2022
Q3
$5.92M Sell
48,275
-37,300
-44% -$4.91M 0.13% 191
2022
Q2
$11.4M Buy
85,575
+5,070
+6% +$691K 0.23% 116
2022
Q1
$11M Buy
80,505
+10,622
+15% +$1.48M 0.18% 147
2021
Q4
$12.1M Buy
69,883
+29,245
+72% +$4.45M 0.18% 160
2021
Q3
$5.91M Buy
40,638
+37,995
+1,438% +$5.56M 0.09% 244
2021
Q2
$349K Buy
+2,643
New +$346K 0.01% 564
2020
Q1
– Sell
-49,233
Closed -$5.26M – 543
2019
Q4
$5.26M Buy
49,233
+16,608
+51% +$1.73M 0.11% 214
2019
Q3
$3.49M Buy
32,625
+4,583
+16% +$470K 0.08% 279
2019
Q2
$2.85M Buy
+28,042
New +$2.69M 0.06% 293
2015
Q4
– Sell
-49,261
Closed -$3.03M – 529
2015
Q3
$3.03M Buy
49,261
+3,210
+7% +$224K 0.09% 184
2015
Q2
$3.34M Buy
46,051
+1,233
+3% +$91K 0.1% 174
2015
Q1
$3.44M Sell
44,818
-33,420
-43% -$2.39M 0.11% 156
2014
Q4
$5.25M Buy
+78,238
New +$4.94M 0.16% 105

Other funds holding DGX

Great Lakes Advisors's DGX Position: Q3 2023 in Review

Great Lakes Advisors sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 14,934 shares — an estimated $2.1M sold.

Great Lakes Advisors first reported a position in DGX in Q4 2014 and held it in 16 quarters. The position peaked at $12.1M in Q4 2021. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Great Lakes Advisors reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Great Lakes Advisors sold 14,934 Quest Diagnostics shares in Q3 2023, an estimated $2.1M.
  • Great Lakes Advisors first reported a position in Quest Diagnostics in Q4 2014 and held it in 16 quarters.
  • Great Lakes Advisors's Quest Diagnostics position peaked at $12.1M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Great Lakes Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.